Application 219153
- Type
- ANDA
- Sponsor
- BIONPHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FAMOTIDINE | FAMOTIDINE | FOR SUSPENSION;ORAL | 40MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219153-001 | FAMOTIDINE | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | 6a471c1ec25d… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219153-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | 2025-06-23 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | Aphena Pharma Solutions - Tennessee, LLC | 46c6d243-eefc-40ca-8bd4-4c89456f635f | 2021-05-18 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | BluePoint Laboratories | 8c7ca3cc-ff90-42a7-9218-554cf15348a3 | 2021-04-13 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Dr.Reddy's Laboratories Limited | 06d286ce-14b3-4b66-8b42-ac4a10a0fc90 | 2020-11-17 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Aphena Pharma Solutions - Tennessee, LLC | b1839d23-20f4-4651-a7d2-8bc3a7583917 | 2020-07-06 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 1e2003d4-09a3-4cc8-af3d-93d29b9123c0 | 2020-07-01 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 92048836-e692-4ce1-93f4-88b00acabcde | 2019-11-01 | Adverse reactions | Famotidine FAMOTIDINE |
| heartburn relief original strength | FAMOTIDINE | Proficient Rx LP | 5567aaaf-b4f2-4604-b841-c9447e77256c | 2019-10-01 | Warnings | FAMOTIDINE |
| Famotidine | FAMOTIDINE | Teva Pharmaceuticals USA, Inc. | 4c6f4f9e-f3f5-4ecf-9f40-887e037e8847 | 2019-01-01 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Lupin Pharmaceuticals,Inc. | a0bdf4d1-8458-4e4f-95aa-bcc38c0f32f8 | 2017-11-21 | Adverse reactions | Famotidine FAMOTIDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.